Mark A. Glickman
2017
In 2017, Mark A. Glickman earned a total compensation of $1.1M as Former Chief Commercial Officer at Aralez Pharmaceuticals, a 50% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $158,508 |
|---|---|
| Option Awards | $83,697 |
| Salary | $397,000 |
| Stock Awards | $417,779 |
| Other | $11,854 |
| Total | $1,068,838 |
Glickman received $417.8K in stock awards, accounting for 39% of the total pay in 2017.
Glickman also received $158.5K in non-equity incentive plan, $83.7K in option awards, $397K in salary and $11.9K in other compensation.
Rankings
In 2017, Mark A. Glickman's compensation ranked 8,673rd out of 14,666 executives tracked by ExecPay. In other words, Glickman earned more than 40.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,673 out of 14,666 | 41st |
Division Manufacturing | 3,301 out of 5,772 | 43rd |
Major group Chemicals And Allied Products | 1,116 out of 2,075 | 46th |
Industry group Drugs | 887 out of 1,731 | 49th |
Industry Pharmaceutical Preparations | 694 out of 1,333 | 48th |
Source: SEC filing on May 18, 2018.
Glickman's colleagues
We found five more compensation records of executives who worked with Mark A. Glickman at Aralez Pharmaceuticals in 2017.
2017
Adrian Adams
Aralez Pharmaceuticals
Chief Executive Officer
2017
Scott Charles
Aralez Pharmaceuticals
Chief Financial Officer
2017
Andrew Koven
Aralez Pharmaceuticals
President and Chief Business Officer
2017
James Tursi
Aralez Pharmaceuticals
Chief Medical Officer
2017
Michael Kaseta
Aralez Pharmaceuticals